EGFR Exon 19 Deletion Mutations and Systemic/CNS Miliary Metastasis: Clinical Correlations and Response to Therapy

Por Poonia, Seerat, Berge, Eamon, Aisner, Dara L., Damek, Denise, Doebele, Robert C
Publicado em 2014

PATH-48. FUSION TESTING IN ADULT VERSUS PEDIATRIC LOW AND HIGH GRADE BRAIN TUMORS FOR ELIGIBILITY FOR TRIALS

Por Ormond, David, Damek, Denise, Willard, Nicholas, Ewalt, Mark, Kleinschmidt-DeMasters, Bette
Publicado no Neuro Oncol (2018)

Neurolymphomatosis.

Por Baehring, Joachim M., Damek, Denise, Martin, Emily C., Betensky, Rebecca A., Hochberg, Fred H.
Publicado em 2003

QOL-16 HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV...

Por Mohler, Alexander, Ney, Douglas, Gaspar, Laurie, Damek, Denise, Kavanagh, Brian, Reddy, Krishna, Chen, Changhu
Publicado no Neuro Oncol (2015)

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

Por Schmidt, Yao, Kleinschmidt-DeMasters, B.K., Aisner, Dara L., Lillehei, Kevin O., Damek, Denise
Publicado no J Neurooncol (2012)

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma

Por Trusheim, John, Dunbar, Erin, Battiste, James, Iwamoto, Fabio, Mohile, Nimish, Damek, Denise, Bota, Daniela A, Connelly, Jennifer
Publicado no CNS Oncol (2017)

RT-24 EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (...

Por Ney, Douglas, Kleinschmidt-DeMasters, B.K., Carlson, Julie, Damek, Denise, Gaspar, Laurie, Kavanagh, Brian, Waziri, Allen, Lillehei, Kevin, Reddy, Krishna, Chen, Changhu
Publicado no Neuro Oncol (2014)